{"id":"https://openalex.org/W2113136182","doi":"https://doi.org/10.1016/s0014-2999(03)01570-x","title":"The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5\u2032-N-methyluronamide, is protective in two murine models of colitis","display_name":"The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5\u2032-N-methyluronamide, is protective in two murine models of colitis","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2113136182","doi":"https://doi.org/10.1016/s0014-2999(03)01570-x","mag":"2113136182","pmid":"https://pubmed.ncbi.nlm.nih.gov/12694816"},"language":"en","primary_location":{"id":"doi:10.1016/s0014-2999(03)01570-x","doi":"https://doi.org/10.1016/s0014-2999(03)01570-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(03)01570-x","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015112375","display_name":"Jon G. Mabley","orcid":"https://orcid.org/0000-0001-9423-6230","observed_orcids":["https://orcid.org/0000-0001-9423-6230"]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jon Mabley","raw_affiliation_strings":["Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA. jmabley@inotekcorp.com","Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA. jmabley@inotekcorp.com","institution_ids":[]},{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077409122","display_name":"Francisco Garc\u00eda Soriano","orcid":"https://orcid.org/0000-0003-4898-0135","observed_orcids":["https://orcid.org/0000-0003-4898-0135"]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco Soriano","raw_affiliation_strings":["Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA","institution_ids":["https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084119264","display_name":"P\u00e1l Pacher","orcid":"https://orcid.org/0000-0001-7036-8108","observed_orcids":["https://orcid.org/0000-0001-7036-8108"]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P\u00e1l Pacher","raw_affiliation_strings":["Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048760718","display_name":"Gy\u00f6rgy Hask\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gy\u00f6rgy Hask\u00f3","raw_affiliation_strings":["Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA","institution_ids":["https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105420568","display_name":"Anita Marton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita Marton","raw_affiliation_strings":["Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rebecca Wallace","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Wallace","raw_affiliation_strings":["Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833359","display_name":"Andrew L. Salzman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Salzman","raw_affiliation_strings":["Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058049602","display_name":"Csaba Szab\u00f3","orcid":"https://orcid.org/0000-0003-3110-4235","observed_orcids":["https://orcid.org/0000-0003-3110-4235"]},"institutions":[{"id":"https://openalex.org/I4210163227","display_name":"Inotek Pharmaceuticals (United States)","ror":"https://ror.org/05x3tad86","country_code":"US","type":"company","lineage":["https://openalex.org/I4210163227"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Csaba Szab\u00f3","raw_affiliation_strings":["Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA","Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, New Jersey Medical School, UMDNJ, Newark, NJ 01703, USA","institution_ids":["https://openalex.org/I4402554120"]},{"raw_affiliation_string":"Inotek Pharmaceuticals Corporation, Suite 419E, 100 Cummings Center, Beverly, MA 01915, USA","institution_ids":["https://openalex.org/I4210163227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5015112375"],"corresponding_institution_ids":["https://openalex.org/I4210163227"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":2.4813,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.87851782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"466","issue":"3","first_page":"323","last_page":"329"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.08320000022649765,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/a3-adenosine-receptor","display_name":"A3 adenosine receptor","score":0.8769999742507935},{"id":"https://openalex.org/keywords/ib-meca","display_name":"IB-MECA","score":0.9940000176429749},{"id":"https://openalex.org/keywords/colitis","display_name":"colitis","score":0.7860000133514404},{"id":"https://openalex.org/keywords/dextran-sodium-sulphate-induced-colitis","display_name":"dextran sodium sulphate-induced colitis","score":0.9369999766349792},{"id":"https://openalex.org/keywords/il-10-knockout-mice","display_name":"IL-10 knockout mice","score":0.9480000138282776},{"id":"https://openalex.org/keywords/inflammatory-cell-infiltration","display_name":"inflammatory cell infiltration","score":0.671999990940094},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.7929999828338623},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":1.0},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8489999771118164},{"id":"https://openalex.org/keywords/myeloperoxidase","display_name":"myeloperoxidase","score":0.9369999766349792},{"id":"https://openalex.org/keywords/malondialdehyde","display_name":"malondialdehyde","score":0.9679999947547913},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.8519755601882935},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6099206209182739},{"id":"https://openalex.org/C158424129","wikidata":"https://www.wikidata.org/wiki/Q4682275","display_name":"Adenosine A3 receptor","level":5,"score":0.6090242266654968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5373861193656921},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5145708918571472},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5143545866012573},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.48429006338119507},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.47085756063461304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4390656352043152},{"id":"https://openalex.org/C203565725","wikidata":"https://www.wikidata.org/wiki/Q420012","display_name":"Myeloperoxidase","level":3,"score":0.43409931659698486},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.4336818754673004},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42851340770721436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4158346951007843},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.40394359827041626},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39958375692367554},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39596027135849},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33556538820266724},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.1477205455303192}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003092","descriptor_name":"Colitis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003106","descriptor_name":"Colon","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003106","descriptor_name":"Colon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003106","descriptor_name":"Colon","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006471","descriptor_name":"Gastrointestinal Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008315","descriptor_name":"Malondialdehyde","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009195","descriptor_name":"Peroxidase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012002","descriptor_name":"Rectal Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016264","descriptor_name":"Dextran Sulfate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018925","descriptor_name":"Chemokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019402","descriptor_name":"Macrophage Inflammatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043684","descriptor_name":"Receptor, Adenosine A3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054407","descriptor_name":"Chemokine CCL4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054426","descriptor_name":"Chemokine CXCL2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058906","descriptor_name":"Purinergic P1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0014-2999(03)01570-x","doi":"https://doi.org/10.1016/s0014-2999(03)01570-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(03)01570-x","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:12694816","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12694816","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/dd8dcca0-9d75-4025-8af6-1a6c2cbeff05","doi":null,"is_oa":false,"landing_page_url":"https://research.brighton.ac.uk/en/publications/dd8dcca0-9d75-4025-8af6-1a6c2cbeff05","pdf_url":null,"source":{"id":"https://openalex.org/S4306401758","display_name":"University of Brighton Repository (University of Brighton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71637028","host_organization_name":"University of Brighton","host_organization_lineage":["https://openalex.org/I71637028"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mabley, J, Soriano, F G, Pacher, P, Hasko, G, Marton, A, Wallace, R, Salzman, A L & Szabo, C 2003, 'The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5\u2032-N-methyluronamide, is protective in two murine models of colitis', European Journal of Pharmacology, vol. 466, no. 3, pp. 323-329.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G972476749","display_name":"ADENOSINE 3 RECEPTOR AGONIST FOR TREATMENT OF COLITIS","funder_award_id":"R43DK057379","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1546909356","https://openalex.org/W1575186397","https://openalex.org/W1597959509","https://openalex.org/W1770444308","https://openalex.org/W1815757713","https://openalex.org/W1855226200","https://openalex.org/W1905926188","https://openalex.org/W1930389691","https://openalex.org/W1944355206","https://openalex.org/W1968081872","https://openalex.org/W1970866345","https://openalex.org/W1977647049","https://openalex.org/W1980729145","https://openalex.org/W1981190747","https://openalex.org/W1983166305","https://openalex.org/W1984570403","https://openalex.org/W2028882736","https://openalex.org/W2031462278","https://openalex.org/W2031919192","https://openalex.org/W2046530849","https://openalex.org/W2050445005","https://openalex.org/W2051625512","https://openalex.org/W2084422721","https://openalex.org/W2093347287","https://openalex.org/W2105270270","https://openalex.org/W2113855055","https://openalex.org/W2114344808","https://openalex.org/W2120245780","https://openalex.org/W2128090799","https://openalex.org/W2129667982","https://openalex.org/W2146830757","https://openalex.org/W2147817917","https://openalex.org/W2157568930","https://openalex.org/W2162245594","https://openalex.org/W2314424409","https://openalex.org/W2325021350","https://openalex.org/W6637837826","https://openalex.org/W6639909173","https://openalex.org/W6640508942"],"related_works":["https://openalex.org/W2089059885","https://openalex.org/W2097058262","https://openalex.org/W1564720827","https://openalex.org/W2046039057","https://openalex.org/W2988013227","https://openalex.org/W1738785473","https://openalex.org/W2129813173","https://openalex.org/W2107207706","https://openalex.org/W2082738950","https://openalex.org/W3006112224"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}